Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15654726 | 1.00 | SIGMAR1 (0.31) | SIGMAR1 | |
| SCHEMBL15655959 | 1.00 | SIGMAR1 (0.31) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL11570376 | 0.97 | SIGMAR1 (0.30) | SIGMAR1 | |
| SCHEMBL17332149 | 0.97 | — | — | |
| SCHEMBL220818 | 0.97 | — | — | |
| SCHEMBL20136165 | 0.97 | — | — | |
| SCHEMBL17332129 | 0.97 | — | — | |
| SCHEMBL3720697 | 0.94 | — | — | |
| SCHEMBL15657454 | 0.93 | — | — | |
| SCHEMBL15657080 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9475889-B2 | Photoinitiator and photocurable compositions and uses | EASTMAN KODAK COMPANY (US) | 2016-10-25 | — | — | US | claimed |
| US-20150126637-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | BANK OF AMERICA, N.A., AS AGENT | 2015-05-07 | — | — | US | claimed |
| EP-2710044-B1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | EASTMAN KODAK CO (US) | 2015-04-01 | — | — | EP | claimed |
| US-8664287-B2 | Photocuring methods and articles prepared therefrom | Eastman Kodah Company (US) | 2014-03-04 | — | — | US | claimed |
| US-20120295035-A1 | PHOTOCURING METHODS AND ARTICLES PREPARED THEREFROM | BANK OF AMERICA, N.A., AS AGENT | 2012-11-22 | — | — | US | claimed |
| US-20120295999-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | NPEC INC. | 2012-11-22 | — | — | US | claimed |
| US-4133831-A | CARBON MONOXIDE, CHLORINE, AND A PHOSPHINE CHLORIDE COMPOUND AS CATALYST | UBE INDUSTRIES, LTD. (JP) | 1979-01-09 | — | — | US | claimed |
| CN-115785150-B | Preparation method of bis (dicyclohexylphosphino) alkane bidentate phosphine ligand | 陕西瑞科新材料股份有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-115785150-A | Preparation method of bis (dicyclohexylphosphino) alkane bidentate phosphine ligand | 陕西瑞科新材料股份有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-11192875-B2 | Processes for preparing antiviral compounds | GILEAD PHARMASSET LLC (US) | 2021-12-07 | — | — | US | disclosed |
| EP-2735581-B1 | COMPOSITION AND POLYMER | ASAHI CHEMICAL IND (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-3197905-B1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2021-06-30 | — | — | EP | disclosed |
| US-20200392100-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2020-12-17 | — | — | US | disclosed |
| WO-2004074933-A2 | DISSOLUTION RATE MODIFIERS FOR PHOTORESIST COMPOSITIONS | PROMERUS LLC (US) | 2004-09-02 | — | — | WO | disclosed |
| EP-0927577-B1 | Ruthenium metathesis catalyst and method for olefin metathesis using the same | TAKASAGO PERFUMERY CO LTD (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-6313365-B1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| US-6175047-B1 | A CATALYST MIXTURE INCLUDING A RUTHENIUM COMPOUND, A DIHALOGENO COMPOUND, A TERMINAL ALKYNE; AS A CATALYST FOR A CARBON-CARBON BOND FORMATION REACTION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-0927577-A1 | Ruthenium metathesis catalyst and method for producing olefin reaction product by metathesis reaction using the same | Takasago International Corporation (JP) | 1999-07-07 | — | — | EP | disclosed |
| US-4133831-A | CARBON MONOXIDE, CHLORINE, AND A PHOSPHINE CHLORIDE COMPOUND AS CATALYST | UBE INDUSTRIES, LTD. (JP) | 1979-01-09 | — | — | US | disclosed |
| US-4125540-A | WITH ORGANO-PHOSPHORUS COMPOUNDS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1978-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192875-B2 | Processes for preparing antiviral compounds | MAVS, EIF2AK2, SAMHD1 | SIGMAR1 1533/4885 |
| US-20200392100-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SAMHD1 | SIGMAR1 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.